← Back to all trials
Not Yet Recruiting
NCT05707754
A Randomized Trial of a Sphenopalatine Ganglion Block With Bupivacaine for Acute Headache
Conditions: Sphenopalatine Ganglion Nerve Block
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 220
Sponsor: Montefiore Medical Center
Location: United States
Summary
The goal of this clinical trial is to compare the administration and dosage of bupivacaine for sphenopalatine ganglion (SPG) nerve block.
The main question[s] it aims to answer are:Does a high dose (3ml) give more relief than a low dose (1ml)?Does bilateral administration give more relief than unilateral?
Participants with headaches will be asked to lie down and have SPG block performed.Researchers will compare dosage and administration to see how symptoms are reduced.
Eligibility Criteria
Inclusion Criteria:Present to ED for management of headacheHeadache is moderate or severe in intensityExclusion Criteria:Allergy to bupivacaineNasal or sinus surgery
Source: ClinicalTrials.gov (NCT05707754). StuddyBuddy aggregates publicly available trial information.
